Stablecoin Development Corporation (SDEV) Q2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2023 earnings summary
10 Nov, 2026Executive summary
Q2 revenue was $4.6M, up 26% YoY, driven by record wound care sales; operating loss narrowed 37% as expenses were managed.
Digital marketing efficiency supported lower sales and marketing costs while eye care, skin care, and wound care each contributed to sales.
Financial highlights
Q2 net product revenue was $4.6M; gross margin held at 50% YoY, while operating expenses declined 8%.
Sales and marketing expense fell 16% to $1.7M; G&A was $1.9M, consistent YoY.
Operating loss was $1.4M, improving 37% YoY; net loss was $4.0M, or $1.27/share, including a $2.0M non-cash retained earnings reduction tied to the preferred-stock down-round feature.
First-half revenue rose 11% to $7.7M; operating loss improved 32% to $3.1M, while net loss was $5.8M, or $2.21/share.
Outlook and guidance
Eye care is expected to deliver incremental growth for the remainder of 2023, particularly through online sales.
DERMAdoctor strategy shifts toward profitability by focusing on top-selling products and efficient channels, reducing development investment and closing inefficient channels.
The Q2 $1M NeutroPhase order is not expected to repeat in Q3; a smaller order is anticipated in Q4.
Second-half gross margin is expected to be around 55%, as wound care's lower margin moderated the mix.
Latest events from Stablecoin Development Corporation
- A 212.7 million-share resale shelf creates substantial dilution and market-overhang risk.SDEV
Registration filing - SKY gains drove Q3 profit; non-cash warrant accounting shaped nine-month earnings.SDEV
Q3 2026 - A 212.7M-share resale shelf overlays a SKY-focused strategy and substantial dilution risks.SDEV
Registration filing - A 212.9 million-share resale shelf accompanies a SKY-focused treasury strategy and substantial dilution risk.SDEV
Registration filing - Strategic shift to digital assets, new board structure, and updated executive compensation plans.SDEV
Proxy filing - Resale registration for 212M+ shares supports a digital asset strategy centered on SKY.SDEV
Registration filing - Registers 212M+ shares for resale, enabling major investors to exit under strict limits.SDEV
Registration filing - $4.7M H1 staking revenue, 2.29B SKY held, $511.3M H1 net income, and warrant liabilities eliminated.SDEV
Q2 2026 - Net loss narrowed and gross margin rose, but liquidity risks persist despite new capital raised.SDEV
Q2 2024